Loading company…
Aurora-based Sierra Neuropharmaceuticals develops centrally administered small molecule therapies for CNS diseases.
Sierra Neuropharmaceuticals is a biopharmaceutical company based in Aurora, US. It develops and commercializes centrally administered small molecule therapeutics for CNS diseases that are refractory to oral medications. It is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in